Latterell Venture Partners is a company founded in 2001 by Pat Latterell.
Latterell Venture Partners' investments include Viracta Therapeutics, Neuraltus Pharmaceuticals, Aptinyx, Naurex, Transcend Medical, Pulmonx, Transcend Medical, Inova Labs, and TetraLogic Pharmaceuticals.
They have exited investments in Aptinyx, Transcend Medical, OncoMed Pharmaceuticals, Inova Labs, Naurex, TetraLogic Pharmaceuticals, CellBiosciences and Calistoga Pharmaceuticals.